QGEN Qiagen N.V.

NYSE
$49.63

Qiagen N.V. (QGEN) Earnings News

Earnings press releases, previews and reviews for Qiagen N.V. (QGEN), newest first. Our most recent is preview: Qiagen's Rally Raises the Bar as Back-Half Recovery Faces Its First Real Test.

Wednesday November 4, 2026 4:05 PM ET
QIAGEN Reports Full Q3 2026 Results
Tuesday October 27, 2026 7:48 PM ET
Qiagen's Rally Raises the Bar as Back-Half Recovery Faces Its First Real Test
Earnings Whispers · Preview
Wednesday October 21, 2026 5:44 PM ET
QIAGEN reports preliminary Q3 2026 results
Wednesday October 21, 2026 5:43 PM ET
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer
Thursday August 27, 2026 4:05 PM ET
QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
Monday August 24, 2026 9:47 AM ET
QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
Monday August 10, 2026 4:05 PM ET
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
Wednesday August 5, 2026 4:05 PM ET
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook
Wednesday July 15, 2026 4:05 PM ET
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
Wednesday July 15, 2026 8:48 AM ET
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
Tuesday July 14, 2026 4:05 PM ET
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe
Monday June 15, 2026 1:30 AM ET
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
Thursday May 28, 2026 4:05 PM ET
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak